Strafford will be offering a webinar/teleconference entitled "Overcoming §103 Rejections for Biotech and Chemical Patents: Leveraging Recent Decisions and USPTO Guidance" on June 9, 2016 from 1:00 to 2:30 pm (EDT). Dr. Shing-Yi (Cindy) Cheng, Thomas L. Irving, and Dr. Amanda K. Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide guidance for patent counsel for overcoming §103 rejections for biotech and chemical patents, review recent case law and USPTO guidance on §103 patent eligibility, and offer strategies to address §103 rejections. The webinar will review the following issues:
• What evidentiary support should counsel provide to bolster its assertion of validity?
• What strategies should patent counsel implement to overcome §103 rejections for biotech patents?
• How can patent counsel guide applicants in reducing the likelihood of rejection?
The registration fee for the webinar is $297. Those interested in registering for the webinar, can do so here.
Comments